ArticleScientific reports2026
HRV features as potential biomarkers for auxiliary diagnosis in epilepsy.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Heart rate variability in epilepsy and its association with disease duration: a retrospective case-control study.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Epilepsy affects around 70 million people worldwide, and diagnosis is often difficult and delayed, exposing patients to avoidable morbidity and psychosocial burden. Heart rate variability (HRV) is a non-invasive marker of autonomic nervous system function that may be altered in epilepsy and may support clinical decision-making. In this single-center case-control study, we recorded short-term HRV during a standardized cardiovascular autonomic reflex test including supine resting, deep-breathing and three challenges (active standing, Valsalva manoeuvre and sustained handgrip) in 200 adults with epilepsy and 200 age- and sex-matched healthy controls. Patients with epilepsy showed consistently lower HRV than controls. Using HRV and demographic features, we developed logistic regression models to distinguish epilepsy from health in an independent test set. A model integrating rest and sustained handgrip achieved the highest performance, although still only moderate (area under the curve 0.68; sensitivity 0.821; specificity 0.484). Standardized multi-paradigm HRV assessment may therefore provide a feasible, low-cost adjunct to support, but not replace, conventional diagnostic evaluation. However, the single-center design, relatively short recordings and inclusion of only healthy controls limit generalizability, and larger multicenter studies including patients with paroxysmal conditions that mimic epilepsy are needed to determine clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.